Cite
MLA Citation
P. Cramer et al.. “IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL.” Hematological oncology, vol. 35, n.d., pp. 232–233. http://access.bl.uk/ark:/81055/vdc_100047524133.0x000026